Immunovative Therapies

Immunovative Therapies is an Israeli company specializing in using living immune cells for the treatment of cancer and infectious diseases.

Immunovative Therapies, Ltd. (ITL) is an Israeli biopharmaceutical company that was founded in May 2004 with financial support from the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator , a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstanding incubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for treatment of cancer and infectious disease.